Given the known cardiovascular risks associated with both MGUS and MM, NT-proBNP may serve as a useful adjunct marker for assessing overall disease burden and organ function, particularly in older patients with comorbidities. This evidence concerns the gene NPPB and Miyoshi myopathy.